Skip Navigation



Glycobiology Advance Access published online on September 20, 2007

Glycobiology, doi:10.1093/glycob/cwm094
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
17/12/1311    most recent
cwm094v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Moriwaki, K.
Right arrow Articles by Miyoshi, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moriwaki, K.
Right arrow Articles by Miyoshi, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

A high expression of GDP-fucose transporter in hepatocellular carcinoma is a key factor for increases in fucosylation

Kenta Moriwaki1, Katsuhisa Noda2,6,, Takatoshi Nakagawa3, Michio Asahi4, Harumasa Yoshihara2, Naoyuki Taniguchi5, Norio Hayashi6 and Eiji Miyoshi1,*

1 Department of Molecular Biochemistry & Clinical Investigation Osaka University Graduate School of Medicine 1–7, Yamada-oka, Suita, Osaka 565–0871 Japan
2 Osaka Rosai Hospital, 1179–3, Nagasone-cho, Kita-ku, Sakai, Osaka 591–8025 Japan
3 Department of Glycotherapeutics Osaka University Graduate School of Medicine 2–2, Yamada-oka, Suita, Osaka 565–0871 Japan
4 Department of Biochemistry Osaka University Graduate School of Medicine 2–2, Yamada-oka, Suita, Osaka 565–0871 Japan
5 Department of Disease Glycomics, Research Institute for Microbial Diseases Osaka University, Center for Advanced Science & Innovation 2–1, Yamada-oka Suita, Osaka 565–0871 Japan
6 Department of Gastroenterology and Hepatology Osaka University Graduate School of Medicine 2–2, Yamada-oka, Suita, Osaka 565–0871 Japan


* To whom correspondence should be addressed. Phone & FAX: +81-6-6879-2590; E-mail: emiyoshi{at}sahs.med.osaka-u.ac.jp

Received on April 27, 2007; accepted on August 31, 2007

Changes in the levels of fucosylation regulate a biological phenotype of cancer cells and a specific fucosylation such as fucosylated {alpha}-fetoprotein (AFP-L3) has been clinically used as a tumor marker for hepatocellular carcinoma (HCC). However, detailed molecular mechanisms that explain the increased fucosylation in HCC remain unknown despite 10-years of study by these researchers. Fucosylation is regulated by complicated mechanisms that involve several factors: fucosyltransferases, GDP-fucose transporter (GDP-Fuc Tr) and synthetic enzymes of GDP-fucose such as GDP-mannose 4, 6-dehydratase (GMD), GDP-4-keto-6-deoxy-mannose-3, 5-epimerase-4-reductase (FX) and GDP-fucose pyrophosphorylase. In this study, the expression of fucosylation-related genes in HCC tissues was studied and it was found that GDP-Fuc Tr is a key factor for increases in fucosylation. A real-time RT-PCR analysis showed significant increases in GDP-Fuc Tr and FX expression in HCC, and levels of the GMD protein were up-regulated by post-translational modification in HCC tissues. In vitro cell experiments showed that the level of GDP-Fuc Tr was the most significantly correlated with the level of cellular fucosylation and the over-expression of GDP-Fuc Tr dramatically increased fucosylation in Hep3B cells. The importance of GDP-Fuc Tr in the increase of fucosylation observed was also confirmed with immunohistochmical analyses. These findings suggest that the up-regulation of GDP-Fuc Tr plays a pivotal role in increased fucosylation in HCC and represents an attractive target for new treatments and diagnosis for HCC.

Key words: AFP-L3 / fucose / GDP-fucose / GDP-fucose transporter / hepatocellular carcinoma


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J BiochemHome page
E. Miyoshi, K. Moriwaki, and T. Nakagawa
Biological Function of Fucosylation in Cancer Biology
J. Biochem., June 1, 2008; 143(6): 725 - 729.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.